About This Event

Apollomics Inc. (Nasdaq:APLM), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Guo-Liang Yu, PhD, Co-founder, Executive Director, Chairman and Chief Executive Officer of Apollomics, rings the Opening Bell.